The use of neurocognitive testing in the assessment of professional athletes sustaining sports-related concussions has become widespread over the past decade. Baseline neurocognitive testing is now a requirement for athletes in the National Football League (NFL). We present preliminary normative data on a computer based neurocognitive test (Immediate Post Concussion Assessment and Cognitive Testing; ImPACT) for 159 NFL athletes. Also included are summary data on basic biopsychosocial characteristics, including medical, psychiatric, chemical dependency, concussion, learning disability/attention deficit disorder, and symptom variables, and the relevance of each to baseline neurocognitive test scores.
Introduction
Since the initial efforts by Barth and colleagues at the University of Virginia in the late 1980s (Barth et al., 1989) , neuropsychological testing has gained widespread acceptance as a valid strategy for assessing the cognitive effects of sports-related concussion. There now exists a wealth of studies attesting to the utility of neurocognitive testing in the assessment of sports-related concussion (Echemendia, 2006; Lovell, Echemendia, Barth, & Collins, 2004) . Clinical researchers and scientists are now focusing efforts on addressing possible demographic and biopsychosocial variables that may affect baseline neurocognitive test scores in various athletic groups. Brown, Guskiewicz, and Bleiberg (2007) recently investigated the effects of sex, SAT scores, level of alertness, and type of sport on NCAA collegiate athletes' baseline neuropsychological test scores. Using the Automated Neuropsychological Assessment Metrics sports medicine battery (ANAM, originally developed and published by the Army Medical Research and Materiel Command, Fort Detrick, MD), Brown and colleagues found that sex, SAT scores, and alertness level had differential effects on various baseline scores (for a more complete discussion of the ANAM sports medicine battery, see Cernich, Reeves, Sun, & Bleiberg, 2007) .
In the general population of young adults, epidemiologic studies have shown prevalence rates of about 4% for attention deficit disorder (ADD; cited in Wilens, Faraone, & Biederman, 2004) , 6% for a serious psychiatric illness (NIMH, 2008) , .5% for a seizure disorder (Sander & Shorvon, 1996) , 26.6% for any substance abuse/dependence (Kessler et al., 1994) , and 13-16% for headache (Duckro, Tait, & Margolis, 1989; Kryst & Scherl, 1994) . According to the fourth edition of the Diagnostic and Statistical Manual of the American Psychiatric Association, the prevalence of learning disabilities ranges from 2% to 10% ". . . depending on the nature of ascertainment and the definitions applied." (American Psychiatric Association, 1994, p. 47) . The Centers for Disease Control reported a prevalence rate of 1.56 million concussions resulting in emergency department visits, hospitalization, and/or death in the United States in 2003, which translates to a base rate of 538.2 concussions per 100,000 individuals (CDC, 2008) . It is safe to say that the prevalence of sports concussion is not truly known, given that many concussions are unrecognized, un-or under-reported, or treated by certified athletic trainers, primary care physicians, and other medical specialists in the office setting.
Studies from the sports concussion literature have shown that age (Pellman, Lovell, Viano, & Casson, 2006) , gender (Covassin, Swanik, & Sachs, 2003) , learning disability/attention deficit disorder (Collins et al., 1999) , headache status (Mihalik et al., 2005; Register-Mihalik, Guskiewicz, Mann, & Shields, 2007) , and concussion history (Broglio, Ferrara, Piland, & Anderson, 2006; Collie, McCrory, & Makdissi, 2006; Iverson, Brooks, Lovell, & Collins, 2006; Moser, Schatz, & Jordan, 2005) may have effects on baseline and postconcussion neurocognitive performances. What is lacking at present is a study assessing the potential effects of various demographic and biopsychosocial factors on neurocognitive performance in professional football players, as the bulk of studies to date (including those listed above) have focused on high school and collegiate athletes.
Given that routine baseline neurocognitive testing of professional athletes is a relatively recent phenomenon, very few normative studies of this population exist, and even less information is available as to the potential effects of demographic and subjects factors on baseline neurocognitive test performance. Pellman, Lovell, Viano, Casson, and Tucker (2004) presented normative data for National Football League (NFL) athletes on paper and pencil neurocognitive tests. Their study was focused on the utility of these tests in assessing neurocognitive changes post-concussion in a convenience sample of professional football players. The tests included the Hopkins Verbal Memory Test, the Brief Visuospatial Memory Test-Revised, Trail Making Tests Part A and B, Controlled Oral Word Association Test, the Digit Span subtest from the Wechsler Adult Intelligence Scale-III and the Symbol Digit Modalities Test. The number of subjects for each test ranged from 155 to 646. The authors noted a mean age of 25.4 years (range of 20-44, with a median of 24 years). A subset of athletes (n = 95) who incurred a concussion and had follow-up neurocognitive testing was available. Athletes were grouped into those with a reported history of three or fewer concussions and those with fewer than three concussions, but overall concussion rates were not provided. Similarly, little else was reported in terms of demographics or other biopsychosocial variables of those athletes who underwent baseline testing or baseline testing plus post-concussion testing. In a follow-up paper, Pellman et al. (2006) reported on 68 NFL (and 125 high school) athletes who underwent baseline and post-concussion neurocognitive testing with a computer based program (ImPACT-Immediate Post Concussion Assessment and Cognitive Testing; Lovell et al., 2002) . Again, the focus of the study was to assess the utility of a computerized platform in the assessment of concussed high school and professional football players who had undergone baseline cognitive testing. Theses athletes ranged in age from 20 to 34 (mean = 24.3), years of education ranged from 14 to 22 (mean = 15.8), and number of prior concussions ranged from 0 to 4 (mean = .65). Baseline ImPACT raw scores were presented (along with ImPACT scores for two postconcussion follow-up assessments), and are, to our knowledge, the only published normative data on computerized neurocognitive test performance for NFL athletes. It should be noted that normative ImPACT data for high school athletes (mean age = 16.5 years, S.D. = 2.3, and mean education = 10.4 years, S.D. = 2.0) has been published by Schatz, Pardini, Lovell, Collins, and Podell (2006) , and for a mixed high school (71%) and collegiate sample (mean age = 17.3 years, range = 14-22, and mean education = 10.9 years, range 8-16) by Van Kampen, Lovell, Pardini, Collins, and Fu (2006) .
At the time of the above referenced studies of Pellman et al. (2004 Pellman et al. ( , 2006 , neuropsychological testing was a "recommended" but not a mandatory requirement in the NFL. On June 19, 2007, the NFL held a "Health and Safety" meeting in Chicago, and was attended by NFL team physicians, certified athletic trainers, other team medical personnel, NFL League Office representatives, and members from the NFL Players Association (Cason, Viano, & Pellman, 2008) . In addition, expert presenters from the fields of neurology, neurosurgery, neuropsychology, neuroradiology, sports medicine, biomechanical engineering, and athletic training participated in the discussion of mild traumatic brain injury (concussion) in the NFL. One of the conclusions from the meeting was that baseline and post-concussion neuropsychological testing was to become mandatory for all NFL athletes. The type of neuropsychological testing (i.e., paper and pencil or computerized) was not delineated, but it has been reported that at least 29 of the 32 NFL teams now use ImPACT (Lovell, personal communication, April 28, 2008) . Efforts at educating athletes and their families about signs and symptoms of concussion also was mandated (see Cason et al., 2008 , for details of the educational materials).
The purposes of our study are to present preliminary ImPACT normative data on a large group of NFL athletes, and to assess the potential effects of various demographic and biopsychosocial variables on baseline ImPACT scores. Although at first blush it would appear that a study of NFL athletes' neurocognitive and biopsychosocial characteristics is somewhat esoteric, the recent mandate of baseline neurocognitive testing by the NFL in effect begins to create a huge database of normative data for this population. Given the increasing attention given to traumatic brain injury in sports, it is likely that neuropsychologists in the near future will be faced with evaluating professional football players from other professional football leagues (e.g., Arena Football, Canadian Football) where baseline neurocognitive testing may not be routinely performed (or readily available). The preliminary normative data presented in this study may be of value to clinical neuropsychologists needing an appropriate reference group for these patients. Also, while baseline neurocognitive testing is now mandatory in the NFL, there is no assurance that an obtained baseline test will be valid, and in the absence of a valid baseline test, post-concussion comparison with an appropriate normative group would be useful.
Based on the sports concussion literature and our clinical observations over the past decade, we hypothesized that age and education would have no effect on baseline ImPACT scores. We were interested in assessing the possible relationships between history of psychiatric illness, chemical dependency, learning disability/attention deficit disorder (ADD), history of treatment for headache, and prior concussion history on baseline ImPACT scores. We hypothesized that the presence of learning disability/ADD or history of treatment of headache by a physician would affect ImPACT scores adversely. The literature contains reports of potentially cumulative effects of multiple sports-related concussions, as well as studies to the contrary. Given the age group of our athletes, we hypothesized that concussion history would not affect baseline ImPACT scores adversely.
Method
Subjects for this study included 168 unselected "consecutive admissions" to a single NFL team roster during the 2005 through 2007 seasons. All athletes underwent baseline testing individually with a standard computerized neurocognitive test prior to the start of the season. The test was administered by certified athletic trainers who had been trained in test administration by the senior author. Athletes were not given an operational definition of concussion, nor was any education regarding the nature of sports-related concussion provided. Athletes simply responded to the question posed to them by the computerized neurocognitive assessment asking for number of previous concussions. No athlete had sustained a concussion during the 6-month period prior to the baseline test, and no athlete was symptomatic from any concussion incurred in the prior season. No athlete reported taking any prescribed medication with significant central nervous system action (e.g., anxiolytics, anticonvulsants, anti-psychotics, etc.) that could affect neurocognitive test performance adversely.
Neurocognitive and biopsychosocial data were collected with Immediate Postconcussion Assessment and Cognitive Testing (ImPACT), a computer based sports concussion testing platform . ImPACT has been shown to be a valid measure for assessing the neurocognitive effects of sports-related concussion (Iverson, Lovell, & Collins, 2005; . A partial list of the biopsychosocial data collected by ImPACT includes age, gender, handedness, years of education, prior concussions, history of seizures, psychiatric illness, chemical dependency, or learning disability/ADD (LD/ADD), and any history of brain infection/surgery or headache treatment by a physician. Quantitatively, ImPACT yields four clinical composite scores, including verbal memory, visual memory, visual-motor (processing) speed, and reaction time. ImPACT also contains the impulse control composite, a validity index score. Finally, ImPACT provides a total symptom score, which is the arithmetic sum of athlete-endorsed symptoms rated on a 1-6 Likert scale (with higher scores reflecting higher level of symptom endorsement).
Results

Descriptive statistics and characteristics of the sample
Of the 168 initial participants, 9 were lost to the study because of responses to ImPACT that were judged to be of questionable technical satisfaction (Impulse Control score of >30; see Lovell, 2007) , and an additional participant was removed from the data set because of extreme outlier status and undue influence on the fit of the succeeding models (Belsley, Kuh, & Welch, 1980) . See Table 8 for the means and standard deviations of the ImPACT variables for the excluded athletes.
The 159 remaining athletes who participated in the study were, on average, 27 years of age (S.D. = 2.89 years) and had an average of 16.5 years of education (S.D. = .81). Ninety two percent (92%) of the respondents were right handed, less than 1% of the sample reported either a history of chemical dependency or psychiatric treatment, and 9% reported a history of diagnosed learning disability and/or ADD. No athlete reported a history of seizure, cerebral infection, or neurosurgical intervention for brain injury/disease. A total of 24 individuals in the sample (15%) reported having sought treatment from a physician for headaches (either migraine or other type headache). Sixty two percent (62%) of the sample reported having experienced 0 concussions, and the remaining 38% have experienced between 1 and 4 concussions. The full breakdown of the number experiencing concussions has been presented in Table 1 . A summary of the descriptive statistics on the ImPACT variables including verbal and visual memory, processing speed, reaction time, and total number of symptoms has been summarized in Table 1 .
Tests of hypotheses on the ImPACT scores
Age
Relationships between age and the four primary ImPACT scores were evaluated by bivariate correlation analysis. The Pearson correlation between age and verbal memory was not statistically significant (r(159) = .065; p = .412), nor was the relationship between age and visual memory (r(159) = .079; p = .320), processing speed (r(159) = −.026; p = .742), or reaction time (r(159) = .072; p = .368). Given the absence of an effect for age, the sample was analyzed as a whole as opposed to stratifying by age.
Age was found to be significantly related to the number of prior concussions experienced among these athletes. The number of concussions variable is a count variable and it cannot take on negative values which renders it unsuitable for ordinary least squares regression. Such variables are more appropriately studied by generalized linear models (Myers, Montgomery, & Vining, 2002) . Poisson regression and its associated Poisson probability distributions are especially suited to count data since these nonlinear models of the exponential family insure the proper underlying probability distributions for statistical tests of significance. These models also guarantee that predicted scores cannot fall outside the range of [0, ∞], e.g., negative predicted values of the dependent variable cannot occur.
For the present data, the Poisson regression of number of concussions on age yielded the fitted modelμ = e −2.88+.087(Age) . It is characteristic of Poisson regression models that the parameter estimates are related to percentage change in the response variable given unit changes in the predictor variable. In the present model, the positive relationship (.087) indicates that for every 1 year increase in age the predicted mean of the number of concussions increases by 9.1% (e.g., [1 − e .087 ] × 100 = 9.1), and this rate of change is significantly different from zero (Wald χ 2
(1) = 8.69, p < .001). This age-concussion relationship suggests the notion that age is likely a proxy for the number of years that any individual has engaged in an athletic activity or that constant levels of activity incur increasing risk with advancing age (i.e., amount of athletic exposures).
Age was also evaluated as a possible predictor of the total number of symptoms observed among this group of athletes. Since number of symptoms is a count variable, a Poisson regression model was fitted to the data by regressing number of symptoms on age. The predicted mean number of symptoms based on age is given byμ = e .762+. 015(Age) which reveals that for each year increase in age results in a 1.5% increase in mean total symptoms. This change is not statistically significant (Wald χ 2
(1) = .98, p < .322).
Education
Education was classified into three groups based on number of years completed: 15 (n = 16), 16 (n = 62), and 17-20 (n = 81) groups. ANOVA yielded no significant differences between education groups for any of the four ImPACT scale scores or for symptom total.
History of psychiatric treatment
Only 2 of 159 (1.3%) individuals reported any prior psychiatric treatment, which is far less than the base rates of serious psychiatric illness in the general population, as discussed in Section 1. There is too little variability on this variable for it to be related to any of the remaining study variables. Hence, no further analyses are performed.
History of chemical dependency
One of 159 participants (less than 1%) reported any history of treatment for chemical dependency which is also well below the base rates for chemical dependency in the general population. There is virtually no variability in this index and it cannot, therefore, be related to any of the remaining study variables.
History of learning disability/ADD
The history of LD/ADD, classified as yes or no, was found to be significantly related to two of the ImPACT variables. Of the 159 athletes 14 (9%) reported a history of LD/ADD. This finding is generally consistent with the estimated prevalence of LD (2-10%) and ADD (4%) in the general population. Point-biserial correlations (Cohen, Cohen, West, & Aiken, 2003) between the history of LD/ADD variable and each of the four ImPACT scales revealed significant relationships between LD/ADD and verbal memory (r(159) = −.161, p = .042), and visual memory (r(159) = −.236, p = .003). The variables of processing speed (r(159) = −.069, p = .390) and reaction time (r(159) = .035, p = .659) showed no significant relationship to LD/ADD classification.
Treatment for headache
Twenty-two of the one hundred and fifty nine participants (14%) reported having received treatment from a physician for headaches, which is quite consistent with population-based estimates of 13-16%. A comparison of the mean differences between those who received treatment and those who did not revealed differences on several of the ImPACT variables. The 22 individuals who received such treatment had a lower verbal memory score (mean = 83.6, S.D. = 9.9) than the group who sought no treatment (mean = 85.6, S.D. = 10.5). These means do not differ statistically by one-way analysis of variance (F(1, 157) = .77, p = .383). Similar analysis of variance tests on the processing speed variable (mean for Headache group = 33.0, S.D. = 6.6; mean for non-headache group = 34.3, S.D. = 6.0) revealed that the two group means are not significantly different (F(1, 157) = .87, p = .352). It was also found that the means for reaction time (mean for the headache treatment group = .60, mean for the no headache treatment group = .59) did not differ significantly (F(1, 157) = .32, p = .574).
However, for the visual memory variable the means of the headache treated group (72.1, S.D. = 14.8) and the nontreated group (79.4, S.D. = 12.3) were found to differ significantly (F(1, 157) = 6.41, p = .012). The average total reported symptoms score was also compared across headache treatment groups and found to be significantly different (F(1, 157) = 6.41, p = .012). And for the total symptoms variable the treated group reported more symptoms on average (5.4, S.D. = 7.5) than did the non-treated group of participants (2.9, S.D. = 4.4) and this difference is statistically significant (F(1, 157) = 5.00, p = .027). The summary statistics for the ImPACT scales by headache treatment group have been presented in Table 2 .
Relationship of total symptoms to ImPACT scales
A test of the degree to which total symptom scores could be predicted from the combination of the four IMPACT scales was evaluated by means of Poisson regression analysis in which the total symptom score was regressed on verbal memory, visual memory, processing speed and reaction time. The goodness of fit deviance of this model (7.64) indicated that the Poisson model fitted to these data is seriously over-dispersed (Myers et al., 2002) . A Negative Binomial model fitted to the data, which can accommodate the overdispersion for count data, showed acceptable goodness of fit (deviance = 1.84). The parameter estimates for predicting mean total symptoms from the fitted model areμ = e 1.387−.011(verbal)−.009(visual)+.023(process)+1.025(reaction) . For the parameter estimates of this model the estimated percentage change in the mean total symptoms per unit change in the predictors was 1.1% for verbal memory (Wald χ 2
(1) = 1.04, p < .308), .9% for visual memory (Wald χ 2 (1) = 1.14, p < .287), 2.3% for processing speed (Wald χ 2 (1) = 2.09, p < .149), and 10.8% for reaction time/10 (Wald χ 2
(1) = .92, p < .337). The collection of the four ImPACT scores do not account for significant variation in the total symptom score (omnibus Likelihood Ratio χ 2
(1) = 4.77, p = .312) which is consistent with the fact that none of the individual ImPACT variables makes a unique contribution to predicting total symptoms. This highlights the need for neurocognitive testing along with the evaluation of symptoms in sports concussion assessment.
Relationship of number of concussions to ImPACT scores
The number of concussions suffered among this group of individuals ranged from 0 to 4, with an average of .6 concussions. The majority of the participants (62%) reported suffering no concussions, and 38% of the sample reported suffering 1, 2, 3 or 4 concussions. The distribution is documented in Table 1 . Since number of concussions is a count variable, Poisson regression was used to regress the number of concussions on the four ImPACT measures. The Poisson model fit the data acceptably (deviance = 1.42) and the predicted mean number of concussions is given byμ = e −1.149+.003(verbal)−.001(visual)+.032(process)−1.164 (reaction) . For each of the parameter estimates the estimated percentage change in number of concussions per unit change in the predictors was .3% for verbal memory (Wald χ 2 (1) = .08, p < .773), .1% for visual memory (Wald χ 2 (1) = .01, p < .915), 3.2% for processing speed (Wald χ 2 (1) = 3.60, p < .080), and 11% for reaction time/10 (Wald χ 2
(1) = .90, p < .343). 1 A test of the full regression model containing the four ImPACT scales it was found to be not significantly related to the number of concussions (omnibus LR χ 2 (4) = 5.60, p = .231).
An alternative view of this analysis could be approached by testing the differences between the means of the five levels of concussion (i.e., 0-4) on each of the four ImPACT scales. Treating the number of concussions as a fivegroup, one-way analysis of variance set up, the multivariate test of the vector of means (Johnson & Wichern, 1998) of the ImPACT scales reveals no significant differences across concussion groups (Pillai's Trace = .057, multivariate η 2 = .014, approximate F(16, 616) = .56, p = .916). None of the univariate follow-up F-tests revealed any significant pattern of differences-all of the p-values were in the range of .20-.85. Means and standard deviations for the five concussion groups for each of the four ImPACT variables have been presented in Table 3 .
The number of concussions experienced by this group of athletes was also found to be significantly related to the tendency to seek treatment for headache. Among those individuals who reported no concussions 10.2% sought treatment for headache. The comparable figure for those experiencing one or two concussions was 16.7%. Among those athletes who experienced 3 or 4 concussions, a substantially larger number (42.9%) reported seeking treatment for headache. The difference between these rates of seeking treatment given increasing numbers of concussions are statistically significant (chi square = 6.39, p = .041).
Percentile norms for ImPACT scales and total symptoms
Percentile norms for the four ImPACT scales and the total symptom scale have been presented in Tables 4-8 . Norms are constructed for integer valued scores for each scale and are the empirical percentiles of this sample of 159 individuals and are not standardized to a distribution ∼N(0, 1). Table 9 contains 95% confidence intervals for each of the four ImPACT composite scores and the total symptom score for the 159 athletes with valid ImPACT data as well as for those 9 athletes whose data was judged to be invalid (i.e., Impulse Control Composite score >30).
Discussion
We endeavored to present preliminary normative ImPACT data for NFL athletes, and to assess the potential relevance of various biopsychosocial factors on ImPACT scores. Of the 168 athletes initially enrolled in this study, 9 were excluded due to ImPACT scores viewed as questionably valid (defined as an Impulse Control score >30), and one was excluded due to statistical outlier status, resulting in a total exclusion rate of 5.92%. Although no formal measure of effort was utilized in this study, it would appear that 94% of the athletes gave sufficient effort to yield results considered valid by a primary ImPACT validity parameter. This result compares favorably with a prior finding of about an 11% rate of questionably valid paper and pencil neurocognitive baselines previously reported in a high school athletic population (Hunt, Ferrara, Miller, & Macciocchi, 2007) .
Analysis of demographic data indicated that the variables of age and education, as hypothesized, had no effect on ImPACT scores in this sample of professional football players. The average age of 27 years in the athletes in the current study is similar to the prior reports of average age of 25 years (Pellman et al., 2004 (Pellman et al., , 2006 . The mode for years of education in our study was 16, which is similar to the mean years of education (15.8) reported by Pellman (2006) . The education variable had a relatively restricted range, which could have accounted for the findings. The absence of an effect for age or education suggests that professional football players may be treated as a solitary group for normative neurocognitive testing purposes, and that separate norms based on age or education may be unnecessary.
Age was correlated with the number of reported concussions, likely a reflection of the increased opportunity for incurring a concussion as a function of athletic exposures. Thirty-eight percent of the sample (n = 61) had experienced a concussion by the time they reached a professional level of competition. It was found that for every 1-year increase in age, the predicted mean number of concussions increased by 9.1%, a statistically significant finding. In the present data the mean number of concussions for the 22-23-year-old participants (n = 10) was .30. If age is a proxy for exposure, then after 8 years of athletic participation (approximately age 30) we would expect (1.091) 10 = 2.01 times as many concussions on average (.60)-the mean number of concussions would be expected to double by age 30. Age was also related to increasing numbers of reported symptoms over time, but this finding did not reach statistical significance.
The absence of a relationship between prior number of concussions and baseline ImPACT scores is consistent with several prior reports. Iverson et al. (2006) found no group differences in ImPACT scores among groups of never concussed, once concussed, and twice concussed high school and university athletes. Similarly, Broglio et al. (2006) found no relationship between history of concussion (zero, one, two, or three) and performance on ImPACT or the Concussion Resolution Index (HeadMinder; see Erlanger, Feldman, et al., 2003; in university athletes. It should be noted, however, that concussion history has been shown to be related to neurocognitive performance in high school athletes, where symptom-free athletes with a history of two or more concussions performed similarly on paper and pencil neurocognitive tests to athletes who had just experienced a recent concussion (Moser et , 2005) . Killam, Cautin, & Santucci (2005) found that concussion (and contact sports history) was related to paper and pencil neurocognitive test performance in collegiate athletes. The base rates of acknowledged psychiatric treatment or chemical dependency were very low, and constituted only 3 (one psychiatric) of the 159 athletes (1.89%). These rates are well below those of the general population. The small sample and restricted range of these variables precluded statistical analysis. It is of interest to note that all three of these athletes were in the upper age range of the study group.
There was a 9% base rate of reported LD/ADD in the sample (n = 14), which is generally consistent with the base rates of these disorders in the general population. In the current study, the presence of LD/ADD was correlated with lower verbal and visual memory scores on ImPACT, but not on reaction time or processing speed. Thus, we found partial support for the hypothesis that athletes with a history of LD/ADD would have different ImPACT scores at baseline.
The presence of athlete-endorsed headache at baseline testing has been shown to affect baseline and post-concussion total symptom score/severity as well as aspects of computerized neurocognitive test performance (ANAM) in high school and collegiate athletes (Register-Mihalik et al., 2007) . Mihalik et al. (2005) found that concussed adolescent athletes who endorsed headache as an active symptom during the acute post-concussion recovery phase were inferior on quantitative ImPACT scores and had higher symptom endorsement than athletes with no headache complaints post-concussion. In the current study, 15% of the athletes (n = 24) reported a history of treatment for headache by a physician, which is essentially the same as the base rate of significant headache in the general population of young adults. At baseline, however, only one of the 24 athletes in the current study reported the presence of headache on the ImPACT symptom checklist. As a group, these athletes had lower ImPACT scores than athletes who had not been treated for headache by a physician. However, only the visual memory difference reached statistical significance, and there were no significant group differences on the other quantitative ImPACT variables. There was, however, an apparent linear relationship between number of concussions sustained and the tendency to seek treatment from a physician Downloaded from https://academic.oup.com/acn/article-abstract/23/5/563/3120 by guest on 25 December 2018 for headache. Again, partial support was noted for the hypothesis that NFL athletes with physician-treated headache syndromes had baseline ImPACT scores that differed from their non-headache treated peers. The above noted trend raises the question as to whether an athlete has truly returned to "normal" once the athlete reports being asymptomatic and has neurocognitive scores that are not significantly different from baseline. Most authoritative statements on return to play after a sports concussion (e.g., McCrory et al., 2005) recommend that an athlete have a normal neurologic examination, is asymptomatic at rest and after exertion, has normal neuroimaging scans (if done), and has neurocognitive test scores (if done) that are considered normal or consistent with an athlete's baseline. Recent functional magnetic resonance imaging (fMRI) studies of concussed athletes (e.g., Chen, Johnston, Collie, McCrory, & Ptito, 2007; Chen, Johnston, Petrides, & Ptito, 2008) indicate that symptoms may persist post-concussion after an athlete's neurocognitive test scores have returned to normal (or baseline), and that these abnormalities are evident on fMRI in terms of hyperactivation or hypoactivation of key cortical areas. Similar electrophysiologic findings have been reported by Gosselin, Theriault, Leclerc, Montpalaisir, and Lassonde (2006) . If an athlete under-reports symptoms post concussion, or is otherwise able to mask them in an attempt to gain clearance for return to play, then persistent headache may be the resultant net effect.
It is becoming clear that headache is a relevant variable in baseline and post-concussion symptom endorsement and neurocognitive functioning in adolescent and adult athletes. Studies have addressed various aspects of headache and its effects on symptom endorsement and neurocognitive functioning in athletes, but it appears that greater clarification of the headache variable will be required in future studies. In particular, studies are indicating that headache may need to be stratified according to migraine versus non-migraine, presence or absence of headache symptom endorsement at baseline, along with history of headache treatment by a physician. There are several limitations to our study. First, all data related to prior medical, psychiatric, chemical dependency, concussion, and learning disability/ADD history information is based on athlete self-report, and no independent confirmation was available. Second, we were unable to partial the learning disability/ADD variable more specifically, and by default, these conditions were treated unitarily. Further research should endeavor to separate these two general conditions more specifically, as it is possible that subtypes of ADD spectrum disorders (as well as subtypes of learning disabilities) may exert differential effects on neurocognitive baseline scores. Third, all athletes in this study were members of a single NFL team. It is unclear whether the data presented from a single team will be generalizable to other NFL athletes. Fourth, athletes in this study were male, and the results are unlikely to be generalizable to female professional athletes in this general age range, as recent studies have reported gender differences in baseline neurocognitive (ImPACT) and symptom scores in collegiate athletes (Covassin et al., 2006) as well as post-concussion neurocognitive scores (e.g., Broshek et al., 2005; Covassin, Schatz, & Swanik, 2007) . 
